| Primary |
| Product Used For Unknown Indication |
34.7% |
| Contraception |
22.0% |
| Post Coital Contraception |
20.4% |
| Oral Contraception |
3.7% |
| Depression |
3.3% |
| Menorrhagia |
2.9% |
| Epilepsy |
2.0% |
| Menstrual Disorder |
2.0% |
| Drug Use For Unknown Indication |
1.6% |
| Bronchitis |
1.2% |
| Acne |
0.8% |
| Hormone Replacement Therapy |
0.8% |
| Migraine |
0.8% |
| Ovarian Cyst |
0.8% |
| Pharyngitis |
0.8% |
| Cough |
0.4% |
| Endometriosis |
0.4% |
| Herpes Virus Infection |
0.4% |
| Hypothyroidism |
0.4% |
| Influenza Like Illness |
0.4% |
|
| Vomiting |
9.2% |
| Menstrual Disorder |
8.3% |
| Pregnancy After Post Coital Contraception |
8.3% |
| Pregnancy With Contraceptive Device |
8.3% |
| Vaginal Haemorrhage |
8.3% |
| Device Dislocation |
5.5% |
| Maternal Exposure During Pregnancy |
5.5% |
| Deep Vein Thrombosis |
4.6% |
| Nausea |
4.6% |
| Uterine Leiomyoma |
4.6% |
| Uterine Perforation |
4.6% |
| Abortion Spontaneous |
3.7% |
| Arrhythmia |
3.7% |
| Pain |
3.7% |
| Weight Decreased |
3.7% |
| Abdominal Pain |
2.8% |
| Breast Cancer |
2.8% |
| Cerebrovascular Accident |
2.8% |
| Congenital Anomaly |
2.8% |
| Dermatitis Atopic |
2.8% |
|
| Secondary |
| Post Coital Contraception |
33.0% |
| Contraception |
14.5% |
| Product Used For Unknown Indication |
8.0% |
| Drug Use For Unknown Indication |
7.1% |
| Pain |
5.4% |
| Urinary Tract Infection |
5.4% |
| Bipolar Disorder |
3.4% |
| Oral Contraception |
2.8% |
| Anxiety Disorder |
2.0% |
| Constipation |
2.0% |
| Depression |
2.0% |
| Extrapyramidal Disorder |
2.0% |
| Anaemia |
1.7% |
| Asthma |
1.7% |
| Epilepsy |
1.7% |
| Hodgkin's Disease |
1.7% |
| Psychotic Disorder |
1.7% |
| Migraine |
1.4% |
| Osteopenia |
1.1% |
| Restless Legs Syndrome |
1.1% |
|
| Menstruation Irregular |
18.3% |
| Menstruation Delayed |
11.8% |
| Vomiting |
10.8% |
| Unintended Pregnancy |
6.5% |
| Abdominal Pain |
4.3% |
| Abortion Induced |
4.3% |
| Breast Cancer |
4.3% |
| Metrorrhagia |
4.3% |
| Muscle Spasms |
4.3% |
| Nausea |
4.3% |
| Breast Tenderness |
3.2% |
| Pregnancy After Post Coital Contraception |
3.2% |
| Pregnancy On Oral Contraceptive |
3.2% |
| Premature Baby |
3.2% |
| Vaginal Haemorrhage |
3.2% |
| Abortion Spontaneous |
2.2% |
| Amenorrhoea |
2.2% |
| Breast Cyst |
2.2% |
| Dizziness |
2.2% |
| Drug Exposure During Pregnancy |
2.2% |
|
| Concomitant |
| Contraception |
14.8% |
| Product Used For Unknown Indication |
13.5% |
| Hypertension |
9.1% |
| Depression |
8.9% |
| Rheumatoid Arthritis |
7.1% |
| Crohn's Disease |
5.4% |
| Anxiety |
4.4% |
| Hypogonadism Female |
4.4% |
| Gastritis |
4.2% |
| Multiple Sclerosis Relapse |
3.9% |
| Epilepsy |
3.4% |
| Asthma |
2.7% |
| Hiv Infection |
2.5% |
| Convulsions |
2.2% |
| Drug Use For Unknown Indication |
2.2% |
| Follicle-stimulating Hormone Deficiency |
2.2% |
| Fsh Decreased |
2.2% |
| Lh Blood Decreased |
2.2% |
| Luteinizing Hormone Deficiency |
2.2% |
| Post Coital Contraception |
2.2% |
|
| Weight Increased |
17.6% |
| Thyroid Neoplasm |
9.9% |
| Unintended Pregnancy |
9.9% |
| Vomiting |
6.6% |
| Nausea |
5.5% |
| Skin Discolouration |
5.5% |
| Constipation |
4.4% |
| Epilepsy |
3.3% |
| Epstein-barr Virus Antibody Positive |
3.3% |
| Herpes Zoster |
3.3% |
| Pharyngeal Oedema |
3.3% |
| Pregnancy |
3.3% |
| Thrombocytopenia |
3.3% |
| Tremor |
3.3% |
| Vith Nerve Paralysis |
3.3% |
| Vitreous Floaters |
3.3% |
| Withdrawal Syndrome |
3.3% |
| Wrong Technique In Drug Usage Process |
3.3% |
| Abdominal Pain |
2.2% |
| Abortion |
2.2% |
|
| Interacting |
| Fungal Infection |
18.2% |
| Nervousness |
18.2% |
| Thrombosis Prophylaxis |
18.2% |
| Benign Muscle Neoplasm |
9.1% |
| High Risk Sexual Behaviour |
9.1% |
| Hypertension |
9.1% |
| Migraine |
9.1% |
| Product Used For Unknown Indication |
9.1% |
|
| Abdominal Pain |
25.0% |
| Delusional Disorder, Persecutory Type |
25.0% |
| Drug Interaction |
25.0% |
| Uterine Haemorrhage |
25.0% |
|
